Profile data is unavailable for this security.
About the company
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
- Revenue in JPY (TTM)1.10tn
- Net income in JPY127.90bn
- Incorporated1921
- Employees30.69k
- LocationTerumo Corp2-44-1, HatagayaSHIBUYA-KU 151-0072JapanJPN
- Phone+81 333748111
- Fax+81 333748399
- Websitehttps://www.terumo.co.jp
Mergers & acquisitions
| Acquired company | 4543:TYO since announced | Transaction value |
|---|---|---|
| OrganOx Ltd | -28.35% | 1.50bn |
| WuXi Biologics (Cayman) Inc-Drug Product (DP) Plant | -29.54% | 167.76m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Olympus Corp | 987.51bn | 84.80bn | 1.73tn | 29.30k | 20.47 | 2.20 | 11.30 | 1.75 | 75.61 | 75.63 | 882.16 | 702.36 | 0.6894 | 1.62 | 5.12 | 33,706,730.00 | 5.92 | 6.74 | 8.27 | 9.51 | 66.24 | 66.85 | 8.59 | 10.69 | 1.09 | 23.11 | 0.2352 | 21.13 | 6.53 | 5.72 | 342.69 | 14.22 | -0.2194 | 14.87 |
| Fisher & Paykel Healthcare Corporatn Ltd | 199.79bn | 40.45bn | 2.03tn | 7.51k | 50.86 | 11.12 | 37.57 | 10.15 | 0.7393 | 0.7393 | 3.65 | 3.38 | 0.852 | 2.36 | 7.66 | 287,543.30 | 17.25 | 15.58 | 20.70 | 18.80 | 63.38 | 61.70 | 20.25 | 18.46 | 1.37 | -- | 0.0694 | 58.59 | 15.96 | 9.85 | 184.46 | 5.60 | -9.61 | 9.10 |
| Shanghai United Img Hlthcare Co Ltd | 273.82bn | 38.39bn | 2.33tn | 8.17k | 60.64 | 4.99 | -- | 8.51 | 2.08 | 2.08 | 14.82 | 25.25 | 0.4376 | 1.12 | 2.58 | 1,493,300.00 | 6.04 | 8.24 | 7.99 | 11.87 | 46.38 | 48.34 | 13.81 | 16.40 | 2.03 | -- | 0.0406 | 7.41 | -9.73 | 28.16 | -36.08 | -- | 24.57 | -- |
| Terumo Corp | 1.10tn | 127.90bn | 2.96tn | 30.69k | 23.03 | 1.94 | 13.54 | 2.70 | 86.71 | 86.71 | 742.71 | 1,032.04 | 0.5299 | 1.58 | 5.48 | 35,696,600.00 | 6.19 | 6.14 | 7.68 | 7.27 | 53.33 | 52.58 | 11.68 | 11.69 | 0.8858 | -- | 0.208 | 31.07 | 12.40 | 10.50 | 9.97 | 6.54 | -0.2695 | 13.18 |
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 05 Feb 2026 | 118.11m | 7.98% |
| Amova Asset Management Co., Ltd.as of 15 Sep 2025 | 62.18m | 4.20% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 55.36m | 3.74% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 54.75m | 3.70% |
| BlackRock Fund Advisorsas of 15 Oct 2025 | 46.11m | 3.11% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Sep 2025 | 39.30m | 2.65% |
| BlackRock Japan Co. Ltd.as of 15 Oct 2025 | 34.03m | 2.30% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 22 Jul 2024 | 29.17m | 1.97% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 26.59m | 1.80% |
| Geode Capital Management LLCas of 12 Feb 2026 | 16.49m | 1.11% |
